These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 29183741)
21. Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability. Jena S; Horn J; Suryanarayanan R; Friess W; Aksan A Pharm Res; 2017 Feb; 34(2):462-478. PubMed ID: 27981449 [TBL] [Abstract][Full Text] [Related]
22. Stabilization of rasburicase and physico-chemical characterization of the resulting injectable formulation. Bayol A; Breul T; Dupin P; Menegotto J; Aleman C; Duplaa H; Faure P; Bonnet MC; Bauer M Drug Dev Ind Pharm; 2004 Sep; 30(8):877-89. PubMed ID: 15521333 [TBL] [Abstract][Full Text] [Related]
23. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design. Beirowski J; Inghelbrecht S; Arien A; Gieseler H J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957 [TBL] [Abstract][Full Text] [Related]
24. Physical Stability of Freeze-Dried Isomalt Diastereomer Mixtures. Koskinen AK; Fraser-Miller SJ; Bøtker JP; Heljo VP; Barnsley JE; Gordon KC; Strachan CJ; Juppo AM Pharm Res; 2016 Jul; 33(7):1752-68. PubMed ID: 27059921 [TBL] [Abstract][Full Text] [Related]
25. Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations. Thakral S; Sonje J; Munjal B; Suryanarayanan R Adv Drug Deliv Rev; 2021 Jun; 173():1-19. PubMed ID: 33741437 [TBL] [Abstract][Full Text] [Related]
26. The importance of individual protein molecule dynamics in developing and assessing solid state protein preparations. Hill JJ; Shalaev EY; Zografi G J Pharm Sci; 2014 Sep; 103(9):2605-2614. PubMed ID: 24867196 [TBL] [Abstract][Full Text] [Related]
27. A spray freeze dried micropellet based formulation proof-of-concept for a yellow fever vaccine candidate. Clénet D; Hourquet V; Woinet B; Ponceblanc H; Vangelisti M Eur J Pharm Biopharm; 2019 Sep; 142():334-343. PubMed ID: 31306751 [TBL] [Abstract][Full Text] [Related]
28. Physical characterization of pharmaceutical formulations in frozen and freeze-dried solid states: techniques and applications in freeze-drying development. Liu J Pharm Dev Technol; 2006 Feb; 11(1):3-28. PubMed ID: 16544906 [TBL] [Abstract][Full Text] [Related]
29. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins III: collapse during storage at elevated temperatures. Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G Eur J Pharm Biopharm; 2013 Oct; 85(2):240-52. PubMed ID: 23727369 [TBL] [Abstract][Full Text] [Related]
30. Freeze-drying of proteins with glass-forming oligosaccharide-derived sugar alcohols. Kadoya S; Fujii K; Izutsu K; Yonemochi E; Terada K; Yomota C; Kawanishi T Int J Pharm; 2010 Apr; 389(1-2):107-13. PubMed ID: 20097277 [TBL] [Abstract][Full Text] [Related]
31. Spectroscopic evaluation of the stabilization of humanized monoclonal antibodies in amino acid formulations. Tian F; Middaugh CR; Offerdahl T; Munson E; Sane S; Rytting JH Int J Pharm; 2007 Apr; 335(1-2):20-31. PubMed ID: 17141436 [TBL] [Abstract][Full Text] [Related]
32. Effects of drying method and excipient on the structure and physical stability of protein solids: Freeze drying vs. spray freeze drying. Mutukuri TT; Wilson NE; Taylor LS; Topp EM; Zhou QT Int J Pharm; 2021 Feb; 594():120169. PubMed ID: 33333176 [TBL] [Abstract][Full Text] [Related]
33. Investigation of the stabilisation of freeze-dried lysozyme and the physical properties of the formulations. Liao YH; Brown MB; Martin GP Eur J Pharm Biopharm; 2004 Jul; 58(1):15-24. PubMed ID: 15207533 [TBL] [Abstract][Full Text] [Related]
34. Practical formulation and process development of freeze-dried products. Schwegman JJ; Hardwick LM; Akers MJ Pharm Dev Technol; 2005; 10(2):151-73. PubMed ID: 15926665 [TBL] [Abstract][Full Text] [Related]
35. Histidine as a versatile excipient in the protein-based biopharmaceutical formulations. Lv JY; Ingle RG; Wu H; Liu C; Fang WJ Int J Pharm; 2024 Sep; 662():124472. PubMed ID: 39013532 [TBL] [Abstract][Full Text] [Related]
36. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage. Lueckel B; Helk B; Bodmer D; Leuenberger H Pharm Dev Technol; 1998 Aug; 3(3):337-46. PubMed ID: 9742554 [TBL] [Abstract][Full Text] [Related]
37. Near-infrared imaging for high-throughput screening of moisture induced changes in freeze-dried formulations. Trnka H; Palou A; Panouillot PE; Kauppinen A; Toiviainen M; Grohganz H; Alcalà M; Juuti M; Ketolainen J; Rantanen J J Pharm Sci; 2014 Sep; 103(9):2839-2846. PubMed ID: 24665039 [TBL] [Abstract][Full Text] [Related]
38. Isomalt and its diastereomer mixtures as stabilizing excipients with freeze-dried lactate dehydrogenase. Tuderman AK; Strachan CJ; Juppo AM Int J Pharm; 2018 Mar; 538(1-2):287-295. PubMed ID: 29341910 [TBL] [Abstract][Full Text] [Related]
39. Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. Costantino HR; Firouzabadian L; Wu C; Carrasquillo KG; Griebenow K; Zale SE; Tracy MA J Pharm Sci; 2002 Feb; 91(2):388-95. PubMed ID: 11835198 [TBL] [Abstract][Full Text] [Related]
40. On the role of excipients in biopharmaceuticals manufacture: Modelling-guided formulation identifies the protective effect of arginine hydrochloride excipient on spray-dried Olipudase alfa recombinant protein. Sharma A; Cazade P; Khamar D; Hayden A; Thompson D; Hughes H Int J Pharm; 2024 Sep; 662():124466. PubMed ID: 39009288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]